Publikace
- Carbonyl-reducing enzymes as targets of a drug-immobilised affinity carrier2015 | Farmaceutická fakulta v Hradci Králové
- Isoquinoline alkaloids as a novel type of AKR1C3 inhibitors2014 | Farmaceutická fakulta v Hradci Králové
- Efficient isolation of carbonyl-reducing enzymes using affinity approach with anticancer drug oracin as a specific ligand2013 | Farmaceutická fakulta v Hradci Králové
- Partial purification and characterization of new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin2009 | Ústřední knihovna
- Partial purification and characterization of new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin2009 | Farmaceutická fakulta v Hradci Králové
- Reduction of anticancer drug doxorubicin by recombinant AKR1C3Publikace bez příslušnosti k fakultě
- Reduction of anticancer drugs doxorubicin and oracin by recombinant AKR1C3Publikace bez příslušnosti k fakultě
- Role of AKR1C3 in metabolism of anticancer drug oracinPublikace bez příslušnosti k fakultě
- Initial characterization of human DHRS1 (SDR19C1), a member of the short chain dehydrogenase/reductase superfamily2019 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- AKR1C3 Inhibitory Potency of Naturally-occurring Amaryllidaceae Alkaloids of Different Structural Types2017 | Farmaceutická fakulta v Hradci Králové
Loading network view...